Stephen E. Karp

3.1k total citations · 1 hit paper
23 papers, 2.2k citations indexed

About

Stephen E. Karp is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Stephen E. Karp has authored 23 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Oncology and 9 papers in Immunology. Recurrent topics in Stephen E. Karp's work include Immunotherapy and Immune Responses (8 papers), Breast Cancer Treatment Studies (7 papers) and Virus-based gene therapy research (6 papers). Stephen E. Karp is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Breast Cancer Treatment Studies (7 papers) and Virus-based gene therapy research (6 papers). Stephen E. Karp collaborates with scholars based in United States, Canada and Australia. Stephen E. Karp's co-authors include William D. Foulkes, Nicholas P. Restifo, Steven A. Rosenberg, James J. Mulé, Rami Younan, Muriel Brackstone, André Robidoux, Claire Holloway, David R. McCready and Brigitte Poirier and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Stephen E. Karp

23 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

2014 555 citations Jean-François Boileau, Brigitte Poirier et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen E. Karp United States	14	946	783	568	566	559	23	2.2k
David W. Kindelberger United States	23	554 0.6×	768 1.0×	607 1.1×	270 0.5×	354 0.6×	38	3.6k
Bjarni A. Agnarsson Iceland	27	556 0.6×	714 0.9×	799 1.4×	854 1.5×	344 0.6×	80	2.7k
Cliff Meldrum Australia	24	789 0.8×	1.1k 1.4×	778 1.4×	619 1.1×	159 0.3×	57	2.6k
Natalja T. ter Haar Netherlands	26	545 0.6×	677 0.9×	190 0.3×	445 0.8×	384 0.7×	51	2.1k
Horst Bürger Germany	24	807 0.9×	954 1.2×	242 0.4×	357 0.6×	305 0.5×	59	3.0k
Maria J. Worsham United States	29	516 0.5×	592 0.8×	401 0.7×	303 0.5×	132 0.2×	82	2.1k
Kathryn M. Verbanac United States	22	638 0.7×	346 0.4×	127 0.2×	453 0.8×	366 0.7×	42	1.7k
Joost J. Oudejans Netherlands	34	386 0.4×	1.3k 1.7×	306 0.5×	1.3k 2.3×	815 1.5×	68	3.0k
Nobuyuki Susumu Japan	32	743 0.8×	656 0.8×	224 0.4×	363 0.6×	268 0.5×	140	3.1k
J. Kærn Norway	36	515 0.5×	809 1.0×	278 0.5×	299 0.5×	213 0.4×	111	3.5k

Countries citing papers authored by Stephen E. Karp

Since Specialization

Citations

This map shows the geographic impact of Stephen E. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Karp more than expected).

Fields of papers citing papers by Stephen E. Karp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Karp. The network helps show where Stephen E. Karp may publish in the future.

Co-authorship network of co-authors of Stephen E. Karp

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen E. Karp. A scholar is included among the top collaborators of Stephen E. Karp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen E. Karp. Stephen E. Karp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boileau, Jean-François, Brigitte Poirier, Mark Basik, et al.. (2014). Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study. Journal of Clinical Oncology. 33(3). 258–264. 555 indexed citations breakdown →

Boileau, Jean-François, Brigitte Poirier, Mark Basik, et al.. (2013). Sentinel node biopsy following neoadjuvant chemotherapy in biopsy proven node positive breast cancer: The SN FNAC study.. Journal of Clinical Oncology. 31(15_suppl). 1018–1018. 3 indexed citations

Boileau, Jean-François, Brigitte Poirier, Mark Basik, et al.. (2013). Sentinel node biopsy after neoadjuvant therapy: Relevance of sentinel node micrometastases, isolated tumor cells, and value of immunohistochemistry.. Journal of Clinical Oncology. 31(26_suppl). 52–52. 2 indexed citations

Cassel, J. Brian, Brian Kaplan, Stephen E. Karp, et al.. (2003). Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. Journal of Surgical Oncology. 84(2). 57–62. 20 indexed citations

Arthur, D.W., M.R. Arnfield, R.D. Zwicker, et al.. (2001). Recall reactions and early breast fibrosis with the use of adriamycin following lumpectomy and brachytherapy only for early stage breast cancer. International Journal of Radiation Oncology*Biology*Physics. 51(3). 159–159. 3 indexed citations

Karp, Stephen E.. (2000). Clinical management of BRCA1- and BRCA2-associated breast cancer. Seminars in Surgical Oncology. 18(4). 296–304. 8 indexed citations

Bear, Harry D., et al.. (2000). Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution. Breast Cancer Research and Treatment. 60(3). 277–283. 10 indexed citations

Chan, Hong‐Lin, et al.. (1999). Hexokinase Type II: A Novel Tumor-Specific Promoter for Gene-Targeted Therapy Differentially Expressed and Regulated in Human Cancer Cells. Human Gene Therapy. 10(2). 155–164. 55 indexed citations

Karp, Stephen E.. (1998). Low-Dose Intravenous Bolus Interleukin-2 with Interferon-Alpha Therapy for Metastatic Melanoma and Renal Cell Carcinoma. Journal of Immunotherapy. 21(1). 56–61. 11 indexed citations

10.

Sadeghi, Nader, et al.. (1997). Generation of Therapeutic T Cells From Draining Lymph Nodes in a Murine Model of Head and Neck Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 123(1). 25–30. 7 indexed citations

11.

Karp, Stephen E., et al.. (1997). Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer. 80(3). 435–441. 131 indexed citations

12.

Karp, Stephen E.. (1997). . Cancer. 80(3). 435–435. 1 indexed citations

13.

Foulkes, William D., Nora Wong, Jean‐Sébastien Brunet, et al.. (1997). Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.. PubMed. 3(12 Pt 1). 2465–9. 92 indexed citations

14.

Hier, Michael, Martin J. Black, George Shenouda, Nader Sadeghi, & Stephen E. Karp. (1995). A murine model for the immunotherapy of head and neck squamous cell carcinoma. The Laryngoscope. 105(10). 1077–1080. 33 indexed citations

15.

McGeehan, Gerard M., J. David Becherer, Robert C. Bast, et al.. (1994). Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370(6490). 558–561. 485 indexed citations

16.

Shiloni, Eitan, Stephen E. Karp, Mary Custer, et al.. (1993). Retroviral transduction of interferon-? cDNA into a nonimmunogenic murinefibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunology Immunotherapy. 37(5). 286–292. 22 indexed citations

17.

Karp, Stephen E., Patrick Hwu, Alik Farber, et al.. (1992). In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor. The Journal of Immunology. 149(6). 2076–2081. 23 indexed citations

18.

Restifo, Nicholas P., et al.. (1992). A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.. The Journal of Experimental Medicine. 175(6). 1423–1431. 140 indexed citations

19.

Rosenberg, Steven A., W. French Anderson, Michael Blaese, et al.. (1992). Immunization of Cancer Patients Using Autologous Cancer Cells Modified by Insertion of the Gene for Interleukin-2 (National Institutes of Health). Human Gene Therapy. 3(1). 75–90. 33 indexed citations

20.

Rosenberg, Steven A., Michael T. Lotze, Jiacai Yang, et al.. (1989). Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.. Journal of Clinical Oncology. 7(12). 1863–1874. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact